PhoenixBio Co Ltd (6190)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:PhoenixBio Co Ltd (6190) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8011829
◆発行会社(調査会社):GlobalData
◆発行日:2017年12月13日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:日本
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
PhoenixBio Co Ltd (PhoenixBio) is a life science company that offers medical therapy solutions. The company offers contract study services which include dosing of test-compounds, sampling, in-life phase trials, chemical analysis, measurement of human albumin levels, and metabolic enzymes and blood biochemical measurements. It also offers histopathological obsevations, serum biomarker studies, toxicogenomics, viral hepatitis related studies, safety studies for human specific molecules, in vitro studies using fresh human hepatocytes, and others. The company also develops PXB-mouse, a human liver chimeric mouse model. It operates in Japan and the US. PhoenixBio is headquartered in Higashihiroshima, Japan.

PhoenixBio Co Ltd (6190) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deal Details 10
Equity Offering 10
PhoenixBio to Raise USD1.3 Million in Private Placement of Shares 10
PhoenixBio Raises USD6.4 Million in IPO 11
Acquisition 13
PhoenixBio to Acquire KMT Hepatech for USD4.3 Million 13
PhoenixBio Co Ltd – Key Competitors 14
PhoenixBio Co Ltd – Key Employees 15
PhoenixBio Co Ltd – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Key Facts, 2017 2
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
PhoenixBio Co Ltd, Deals By Therapy Area, 2011 to YTD 2017 8
PhoenixBio Co Ltd, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
PhoenixBio to Raise USD1.3 Million in Private Placement of Shares 10
PhoenixBio Raises USD6.4 Million in IPO 11
PhoenixBio to Acquire KMT Hepatech for USD4.3 Million 13
PhoenixBio Co Ltd, Key Competitors 14
PhoenixBio Co Ltd, Key Employees 15
PhoenixBio Co Ltd, Subsidiaries 16

★海外企業調査レポート[PhoenixBio Co Ltd (6190)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Al Waha Capital P.J.S.C.:企業の戦略・SWOT・財務情報
    Al Waha Capital P.J.S.C. - Strategy, SWOT and Corporate Finance Report Summary Al Waha Capital P.J.S.C. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • The Tokyo Electric Power Company Holdings., Incorporated:企業の戦略・SWOT・財務分析
    The Tokyo Electric Power Company Holdings., Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Tokyo Electric Power Company Holdings., Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the comp …
  • JMC Projects (India) Ltd (JMCPROJECT):企業の財務・戦略的SWOT分析
    JMC Projects (India) Ltd (JMCPROJECT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • TMX Group Ltd (X)
    TMX Group Ltd (X) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company
  • Nordic Nanovector ASA (NANO):企業の財務・戦略的SWOT分析
    Summary Nordic Nanovector ASA (Nordic Nanovector), formerly Nordic Nanovector AS is a developer and commercializer of antibody radionuclide conjugates for the treatment of haematological cancers. The company’s lead product candidate includes Betalutin, an antibody radionuclide conjugate developed fo …
  • A.H.A International Co., Ltd.:戦略・SWOT・企業財務分析
    A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary A.H.A International Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Watchstone Group plc (WTG):企業の財務・戦略的SWOT分析
    Summary Watchstone Group plc (Watchstone) formerly Quindell Plc, is a technology company that offers services such as software; consulting and technology enabled outsourcing services. The company provide solutions such as Hubio, pt Health, ingenie, InnoCare, QuoteSupermarket, and others. It provides …
  • Cutispharma Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary CutisPharma Inc (CutisPharma) is a pharmaceutical company that develops and distributes kits. The company offers products such as oral suspensions, suppositories, oral solutions, and topical, among others. Its oral solutions and oral suspensions include mouthwashes, anti-microbial, and PPIs; …
  • Eesti Energia AS:戦略・SWOT・企業財務分析
    Eesti Energia AS - Strategy, SWOT and Corporate Finance Report Summary Eesti Energia AS - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Assa Abloy AB:企業のM&A・事業提携・投資動向
    Assa Abloy AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Assa Abloy AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments …
  • Marico Limited (MARICO):企業の財務・戦略的SWOT分析
    Marico Limited (MARICO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • China Petroleum & Chemical Corp (600028):企業の財務・戦略的SWOT分析
    China Petroleum & Chemical Corp (600028) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Takara Bio Inc (4974):企業の財務・戦略的SWOT分析
    Summary Takara Bio Inc (Takara), a subsidiary of Takara Holdings Inc, is a biotechnology company that develops, manufactures and distributes biotechnology research reagents and equipments for life sciences research. The company sells gene amplification system and offers scientific instruments. It of …
  • Ygm Trading Ltd.
    Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report Summary Ygm Trading Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Freeport-McMoRan Inc:企業の戦略・SWOT・財務情報
    Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report Summary Freeport-McMoRan Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alere Toxicology Plc:企業の戦略的SWOT分析
    Alere Toxicology Plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and s …
  • Virginia Electric and Power Company:発電所・企業SWOT分析
    Virginia Electric and Power Company – Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information …
  • Adpo Group NV:企業の戦略的SWOT分析
    Adpo Group NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • CPR Pharma Services Pty Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary CPR Pharma Services Pty Ltd (CPR) is a contract research organization that offers drug development and clinical trial services. The organization's services include clinical project management and monitoring, data management, statistical and pharmacokinetic services, and bioanalytical service …
  • Recro Pharma Inc (REPH):製薬・医療:M&Aディール及び事業提携情報
    Summary Recro Pharma Inc (Recro Pharma) is a specialty pharmaceutical company that focuses on developing novel products for commercialization in hospital and other acute care settings and provides contract development and manufacturing (CDMO) services. The company is developing IV/IM Meloxicam, a pr …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆